Yaraş, Serkan <br/><br/>
Real-life results of treatment with ombitasvir, paritaprevir, dasabuvir, and ritonavir combination in patients with chronic renal failure infected with HCV in Turkey.  [electronic resource] 

 -  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology  Apr 2019 
 - 331-335 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>2148-5607 
<br/><br/><label>Standard No.: </label>10.5152/tjg.2018.18269  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Naphthylamine<br/>Adult<br/>Aged<br/>Anilides--administration & dosage<br/>Antiviral Agents--administration & dosage<br/>Carbamates--administration & dosage<br/>Cyclopropanes<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Kidney Failure, Chronic--therapy<br/>Lactams, Macrocyclic<br/>Macrocyclic Compounds--administration & dosage<br/>Male<br/>Middle Aged<br/>Proline--analogs & derivatives<br/>Renal Dialysis<br/>Ritonavir--administration & dosage<br/>Sulfonamides--administration & dosage<br/>Sustained Virologic Response<br/>Turkey<br/>Uracil--administration & dosage<br/>Valine